The Office of Statewide Health Planning and Development has released the mandatory reporting of information related to increases to the wholesale acquisition cost (WAC) of prescription drugs. This release includes all the required information submitted by prescription drug manufacturers for specified WAC increases reported through the second quarter of 2019.